On December 10, 2024, Franklin Berger, a Director at Atea Pharmaceuticals Inc (AVIR, Financial), sold 359,606 shares of the company. Following this transaction, the insider now owns 451,897 shares of the company. The transaction details can be found in the SEC Filing.
Atea Pharmaceuticals Inc (AVIR) is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics. The company's primary aim is to address unmet medical needs by targeting viral infections.
The insider transaction history for Atea Pharmaceuticals Inc indicates that there have been no insider buys over the past year. In contrast, there have been 10 insider sells during the same period. This recent sale by Franklin Berger is part of the broader trend of insider selling within the company.
On the day of Franklin Berger's recent sale, shares of Atea Pharmaceuticals Inc were trading at $2.85 each, resulting in a market cap of $249.165 million for the company.
Over the past year, Franklin Berger has sold a total of 359,606 shares and has not purchased any shares. This activity aligns with the overall insider selling trend observed in the company.
For more information on the company's valuation metrics, such as GF Value, price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, investors can refer to the respective links.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
